A $39.95 cable helped expose an expensive problem: diabetes devices could collect readings faster than people could use them. Glooko built a business around closing that gap - and is taking the idea from the clinic to the hospital.
Sensyne offered hospitals a share of the proceeds from AI research. A cash crisis forced a rescue, a new name and a smaller business - while its pregnancy-diabetes app found a life of its own.